Patents
Patents for C07C 311 - Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (17,647)
09/2002
09/25/2002EP0841912B1 Antitumor 2-aminocarbonyl-1,2-bis(methylsulfonyl)-1-(substituted)hydrazines
09/24/2002US6455587 Aromatic sulfonyl derivatives
09/24/2002US6455582 Treating cancer
09/24/2002US6455581 Inhibitors of hiv protease.
09/24/2002US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/24/2002US6455502 Compounds and compositions as protease inhibitors
09/19/2002WO2002072560A1 Substituted fluoroalcoxyphenylsulfonylurea
09/19/2002WO2002072542A2 Ph-dependent nmda receptor antagonists
09/19/2002WO2002072537A2 Water- and oil-repellency imparting ester oligomers comprising perfluoroalkyl moieties
09/19/2002WO2002072068A2 Lipids, lipid compositions, liposomes, and lipoplexes
09/19/2002WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
09/19/2002US20020132852 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use
09/19/2002DE10113027A1 3-Diaminophenyl-acrylamide derivatives or their physiologically acceptable, water-soluble salts, used as developers in combination with couplers in oxidative dye formulations, especially for dyeing hair are new
09/19/2002DE10111649A1 Substituierte Fluoralkoxyphenylsulfonylharnstoffe Substituted fluoroalkoxyphenylsulfonylureas
09/19/2002DE10109204A1 Use of new and known diphenylurea compounds for the preparation of a medicament for the inhibition of intracellular protein-degradation pathway
09/19/2002DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use
09/19/2002CA2440284A1 Ph-dependent nmda receptor antagonists
09/19/2002CA2439225A1 Water- and oil-repellency imparting ester oligomers comprising perfluoroalkyl moieties
09/18/2002EP1241159A1 Aromatic diamide derivatives, chemicals for agricultural or horticultural use and usage thereof
09/18/2002EP1239852A2 Bissulfonamide derivatives as enzyme inhibitors
09/18/2002EP0975594B1 Process for the production of indole derivatives
09/18/2002EP0934259B1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
09/18/2002EP0917528B1 New amidino derivatives and their use as thrombin inhibitors
09/18/2002CN1370151A Process for preparing 2-amino-4-(4-fluorophenyl)-6-alkylpyrimidine-5-carboxylate
09/18/2002CN1091100C N-acrylsulfilimine compound and their use as catalysts in prepn. of N-arylarylsulfonamide compounds
09/17/2002US6452048 Reacting a fluorinated sulfonyl halide with anhydrous ammonia, or salt thereof
09/17/2002US6452037 Carbonylated, oligoanilinated derivatives; antitumor agents; photosensitizers transforming molecular oxygen into singlet oxygen; bioavailable
09/17/2002US6451859 C16 unsaturated FP-selective prostaglandins analogs
09/17/2002US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451824 Sulfonylaminocarboxylic acids
09/17/2002US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity
09/17/2002US6451792 Matrix metalloprotease inhibitors
09/17/2002US6451791 Amidoaromatic ring sulfonamide hydroxamic acid compounds
09/17/2002US6451497 Diazo compound
09/12/2002WO2002070492A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
09/12/2002WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/12/2002WO2002070470A2 Benzophenones as inhibitors of reverse transcriptase
09/12/2002WO2002070469A2 Selective pde3b inhibitors and use of the same in therapy
09/12/2002WO2002070467A1 Derivatives of diphenylurea, diphenyloxalic acid diamide and diphenylsulfuric acid diamide and their use as medicaments
09/12/2002WO2001049721A3 Bacterial genes and proteins that are essential for cell viability and their uses
09/12/2002US20020128501 Particularly effective in Ru-catalyzed asymmetric hydrogenation of beta-ketoesters to beta-hydroxyesters and ruthenium-catalyzed asymmetric hydrogenation of enamides to beta amino acids; catalyst selectivity
09/12/2002US20020128383 Combinatorial active compound synthesis and its intermediates
09/12/2002US20020128266 ABCA-1 elevating compounds
09/12/2002US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques
09/12/2002US20020128231 Aryl-indane compounds
09/12/2002US20020128208 Such as 4-benzoylamino-(2-(2-hydroxyethyl)-piperazin-1-yl-methyl)-phenyl)-benzene -sulfonamide; for treatment of hypertension; treatment of kidney disorders
09/12/2002US20020127605 Cyclophilin compound for use in the treatment of infections, nervous system, skin, ischemic and vision disorders
09/12/2002CA2440104A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates
09/12/2002CA2439820A1 Benzophenones as inhibitors of reverse transcriptase
09/12/2002CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours
09/11/2002EP1237859A2 Use of bis-sulfonamides for producing medicaments used for preventing or treating hyperlipidaemia
09/11/2002EP1237858A1 Method for preparing imides from sulfonyl fluorides
09/11/2002EP1237849A1 Activators of soluble guanylate cyclase
09/11/2002EP0912504B1 Oxazolidine ester
09/11/2002EP0799206B1 Aryl- and hetaryl-sulfonamide derivatives, their preparation and their use as endothelin antagonists
09/11/2002CN1368961A Compounds for modulation of PPAP gamma activity
09/11/2002CN1368958A Arylsulfonamido-substituted hydroxamic acid derivatives
09/11/2002CN1368957A Aminobenzophenones as inhibiotors of IL-1 beta and TNF-alpha
09/10/2002US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein
09/10/2002US6448293 Treatment or prevention of a disorder in which the regulation of monoamine transporter function is implicated, such as premature ejaculation.
09/10/2002US6448290 Prostaglandin e2 antagonist or agonist; inhibition of uterine contraction, analgesics, antidiarrheals, sleep inducers, increasing vesical capacity, cathartic, suppression of gastric acid secretion, antihypertensive, diuretic agents
09/10/2002US6448254 Substituted amides, their production and their use
09/06/2002WO2002068382A1 Process for preparing sulfamoyl-substituted phenethylamine derivatives
09/06/2002WO2002067918A1 Novel diallylmethylamine derivative
09/06/2002WO2002067865A2 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof
09/05/2002US20020123632 Substituted anthranilic acids, their use as a medicament or diagnostic, and medicament comprising them, and a pharmaceutical combination preparation containing a sodium/hydrogen exchange (NHE) blocker
09/05/2002US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC
09/05/2002US20020123494 For therapy of vagal dysfunction in the heart, improving cardiac function, therapy of person susceptible to cardiac death
09/05/2002DE10110325A1 Phenylderivate 2 Phenyl derivatives 2
09/04/2002EP1235807A1 B-amino acid-, aspartic acid- and diaminopropionic-based inhibitors of factor xa
09/04/2002EP1235797A1 Aralkyl-1,2-diamines having calcimimetic activity and preparation mode
09/04/2002EP0889878B1 Bisarylcyclobutene derivates as cyclooxygenase inhibitors
09/04/2002CN1090020C 4,4-(disubstituted) cyclohexan-1-ols and related compounds
09/04/2002CN1090019C 组合物 The composition
09/03/2002US6444701 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
09/03/2002CA2178085C Glutaramide derivatives
08/2002
08/29/2002WO2002066422A1 Phenethanolamine derivatives for treatment of respiratory diseases
08/29/2002WO2002002520A3 Compounds to treat alzheimer's disease
08/29/2002WO2002002506A3 Compounds to treat alzheimer's disease
08/29/2002WO2002000622A3 Aminoalcohol derivatives
08/29/2002WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors
08/29/2002US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence
08/29/2002US20020120137 FXR modulators
08/29/2002US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity
08/29/2002US20020120007 Benzamide inhibitors of factor Xa
08/29/2002CA2437977A1 Phenethanolamine derivatives for treatment of respiratory diseases
08/28/2002EP1233958A1 Inhibitors of histone deacetylase
08/28/2002EP1233939A1 Process for preparing optically active alpha-hydroxy acids and derivatives thereof
08/28/2002EP0848696B1 2,4-pentadienoic acid derivatives having retinoid-like biological activity
08/28/2002CN1365967A Amine derivative with K channel regulation function and its preparing process and application
08/28/2002CN1365966A Amine derivative for preventing ischemic and anoxia damage of nerve and its medical application
08/27/2002US6441177 (4-bromo-phenyl)-(4-(6-(cyclopropyl-methyl-amino)-hexyloxy)-2-fluoro -phenyl)-methanone; antimycotic and cholesterol lowering activity
08/27/2002US6441021 Type-iv collagenase inhibitors
08/27/2002US6440966 Benzenesulfonamide derivatives and their use as MEK inhibitors
08/27/2002US6440962 Cardiovascular disorders, antiischemic agents
08/27/2002US6440903 Substituted 2,4-diamino-1,3,5-triazines as herbicides
08/27/2002CA2167039C Alkylated (hetero)cyclic compounds; process for preparing the same and pharmaceutical compositions containing them
08/22/2002WO2002064552A1 1g(a)-AMINO-N-HYDROXY-ACETAMIDE DERIVATIVES
08/22/2002WO2002064551A1 Hiv protease inhibitors based on amino acid derivatives
08/22/2002WO2002064550A1 Glucocorticoid receptor modulators